ES8303092A1 - Procedimiento para la obtencion de lapices antimicoticos con mayor liberacion de sustancia activa. - Google Patents

Procedimiento para la obtencion de lapices antimicoticos con mayor liberacion de sustancia activa.

Info

Publication number
ES8303092A1
ES8303092A1 ES509798A ES509798A ES8303092A1 ES 8303092 A1 ES8303092 A1 ES 8303092A1 ES 509798 A ES509798 A ES 509798A ES 509798 A ES509798 A ES 509798A ES 8303092 A1 ES8303092 A1 ES 8303092A1
Authority
ES
Spain
Prior art keywords
stick
drug release
higher rate
antifungal compositions
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES509798A
Other languages
English (en)
Other versions
ES509798A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6125514&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8303092(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES509798A0 publication Critical patent/ES509798A0/es
Publication of ES8303092A1 publication Critical patent/ES8303092A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/05—Stick

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE LAPICES ANTIMICOTICOS. CONSISTE EN MEZCLAR 0,05-1% DE DERIVADOS AZOLICOS ANTIMOCOTICOS, 3-5% DE ALCOHOL BENCILICO, 2,5-10% DE UN AGENTE DISPERSANTE Y LOS MEDIOS AUXILIARES DE FORMULACION USUALES; FUNDIR LA MEZCLA A 70-75 C; VENTILAR EL FUNDIDO; COLARLO EN MOLDES EN FORMA DE LAPIZ; Y DEJAR ENFRIAR. ESTOS LAPICES TIENEN APLICACIONES PARA EL TRATAMIENTO DE LA MICOSIS DE LA PIEL Y APENDICES CUTANEOS.
ES509798A 1981-02-23 1982-02-22 Procedimiento para la obtencion de lapices antimicoticos con mayor liberacion de sustancia activa. Expired ES8303092A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813106635 DE3106635A1 (de) 1981-02-23 1981-02-23 Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Publications (2)

Publication Number Publication Date
ES509798A0 ES509798A0 (es) 1983-02-01
ES8303092A1 true ES8303092A1 (es) 1983-02-01

Family

ID=6125514

Family Applications (1)

Application Number Title Priority Date Filing Date
ES509798A Expired ES8303092A1 (es) 1981-02-23 1982-02-22 Procedimiento para la obtencion de lapices antimicoticos con mayor liberacion de sustancia activa.

Country Status (14)

Country Link
US (1) US4457938A (es)
EP (1) EP0058887B1 (es)
JP (1) JPS57156413A (es)
AT (1) ATE6988T1 (es)
AU (1) AU8032682A (es)
CA (1) CA1169770A (es)
DE (2) DE3106635A1 (es)
DK (1) DK76582A (es)
ES (1) ES8303092A1 (es)
FI (1) FI820563L (es)
IL (1) IL65057A (es)
NO (1) NO820319L (es)
PH (1) PH18258A (es)
ZA (1) ZA821137B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3204124A1 (de) * 1982-02-06 1983-08-18 Bayer Ag, 5090 Leverkusen Antimykotische tampons mit hoher wirkstoff-freisetzung
DE3243546A1 (de) * 1982-11-25 1984-05-30 Bayer Ag, 5090 Leverkusen Antimykotische mittel in gelform zur behandlung von pilzinfektionen der mundhoehle
DE3244027A1 (de) * 1982-11-27 1984-05-30 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von gelsystemen
DE3311700A1 (de) * 1983-03-30 1984-10-04 Bayer Ag Antimykotische mittel mit hoher wirkstoff-freisetzung in form von loesung und spray
DE3311701A1 (de) * 1983-03-30 1984-10-04 Bayer Ag Antimykotische mittel mit hoher wirkstoff-freisetzung in form von creme
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
US4636520A (en) * 1984-07-16 1987-01-13 Fujisawa Pharmaceutical Co., Ltd. Antifungal composition employing pyrrolnitrin in combination with an imidazole compound
DE3520098A1 (de) * 1985-06-05 1986-12-11 Bayer Ag, 5090 Leverkusen Azolderivate enthaltende formulierungen sowie ihre verwendung zur atraumatischen nagelentfernung
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
US4867971A (en) * 1988-04-22 1989-09-19 Colgate-Palmolive Company Low pH shampoo containing climbazole
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
JP2555555B2 (ja) * 1991-07-03 1996-11-20 武田薬品工業株式会社 抗真菌性外用製剤
ZA934007B (en) * 1992-06-08 1994-03-09 Schering Plough Healthcare Stable imidazole anti-fungal powder compositions
US5284649A (en) * 1992-09-29 1994-02-08 The Procter & Gamble Company Deodorant gel sticks containing 1-hydroxy pyridinethione active
EP2007390A4 (en) * 2006-04-04 2009-11-25 Avner Shemer TREATMENT KIT FOR SKIN INFECTION
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
MY179756A (en) 2013-10-03 2020-11-12 Dow Pharmaceutical Sciences Stabilized efinaconazole formulations
EP3071295A4 (en) 2013-11-22 2017-05-31 Dow Pharmaceutical Sciences, Inc. Anti-infective methods, compositions, and devices

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799613A (en) * 1954-09-09 1957-07-16 Merck Ag E Fungicides and bactericides and process of applying
US3502594A (en) * 1965-12-28 1970-03-24 Gerhard W Ahrens Synergistic antioxidant composition for natural oleaginous materials
US3483008A (en) * 1966-08-01 1969-12-09 Daniel A Naeve Method of preparing a water-soluble protein lotion
US3903287A (en) * 1971-02-05 1975-09-02 Bayer Ag Imidazolyl ketones for treating mycotic infections
GB1327853A (en) * 1971-05-24 1973-08-22 Ici Ltd Griseofulvin compositions
US3856931A (en) * 1972-08-01 1974-12-24 Schering Ag Medicated stick
DE2430039C2 (de) * 1974-06-22 1983-11-10 Bayer Ag, 5090 Leverkusen Climbazol in kosmetischen Mitteln
DE2461406C2 (de) * 1974-12-24 1984-06-14 Bayer Ag, 5090 Leverkusen Azolyl-(1)-methane und deren Salze, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE2851116A1 (de) * 1978-11-25 1980-06-12 Bayer Ag Hydroxyethyl-azole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4268498A (en) * 1979-07-16 1981-05-19 Revlon, Inc. Clear cosmetic sticks

Also Published As

Publication number Publication date
FI820563L (fi) 1982-08-24
ATE6988T1 (de) 1984-04-15
IL65057A0 (en) 1982-04-30
DE3260099D1 (en) 1984-05-17
ZA821137B (en) 1983-01-26
IL65057A (en) 1985-06-30
NO820319L (no) 1982-08-24
DE3106635A1 (de) 1982-09-09
PH18258A (en) 1985-05-13
DK76582A (da) 1982-08-24
JPS57156413A (en) 1982-09-27
ES509798A0 (es) 1983-02-01
CA1169770A (en) 1984-06-26
AU8032682A (en) 1982-09-02
EP0058887A1 (de) 1982-09-01
EP0058887B1 (de) 1984-04-11
US4457938A (en) 1984-07-03

Similar Documents

Publication Publication Date Title
ES8303092A1 (es) Procedimiento para la obtencion de lapices antimicoticos con mayor liberacion de sustancia activa.
IL50757A (en) 1-phenyl-2-(1,2,4-triazol-1-yl)-ethyl ether derivatives,their preparation and bactericidal and fungicidal compositions containing them
ES8103051A1 (es) Un metodo de preparar nuevos derivados de pirazolina
DE2966411D1 (en) Imidazolylvinylethers, their preparation and application as active agent in pharmaceutical and biocidal compositions
IL58407A (en) Dioxolanylmethyl-1h-1,2,4-triazole derivatives,their preparation and fungicidal compositions containing them
ES480426A1 (es) Procedimiento para la obtencion de hidroxipropil-imidazoles.
ES8505802A1 (es) Procedimiento para la obtencion de pesticidas a base de microemulsiones en agua.
DE2961994D1 (en) Ethene-azole derivatives, process for their preparation, fungicidal compositions and process for their preparation, use of the azole derivatives in combating fungi and process for combating fungi
ES8307493A1 (es) Procedimiento para preparar una crema grasa terapeutica de rapida absorcion por la piel.
DE3364875D1 (en) A fungicidal composition
NZ195895A (en) Liquid fungicidal composition based on solution/suspension formulation of triforine and carbendazim
JPS5750914A (en) Betamethasone external pharmaceutical
IL57058A (en) Dichlorobenzodioxole derivatives,their preparation and their use as synergistic agents in insecticidal and acaricidal compositions
DE3063427D1 (en) Dihydrothiazine derivatives, their preparation, their inclusion in anthelmintic and pesticidal compositions and their use as anthelmintics and pesticides
EP0004261A3 (en) Imidazole derivatives, method and intermediates for their preparation and pharmaceutical compositions containing such imidazole derivatives, as well as the use of such imidazole derivatives in combating diseases
MY100038A (en) Fungicidal composition